| Bid Price | 1.50p | High Price | 1.55p |
|---|
| Ask Price | 1.55p | Low Price | 1.35p |
|---|
| Open Price | 1.35p | Spread | 3.23% |
|---|
| Prev Close | 1.44p | Volume | 3,944,948 |
|---|
Hemogenyx Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Nov 20, 2024 | 1.50 | 1.60 | 1.35 | 1.44 | 10,093,152 |
| Nov 19, 2024 | 1.25 | 1.70 | 1.25 | 1.52 | 30,124,518 |
| Nov 18, 2024 | 1.25 | 1.39 | 1.14 | 1.36 | 19,248,784 |
| Nov 15, 2024 | 1.00 | 1.25 | 1.00 | 1.20 | 16,359,417 |
| Nov 14, 2024 | 1.07 | 1.15 | 1.00 | 1.05 | 5,799,606 |
Hemogenyx Pharmaceuticals PLC Information
| Name | Hemogenyx Pharmaceuticals PLC | Index | |
|---|
| ISIN | GB00BYX3WZ24 | Epic | HEMO |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 200,000 | Trading Status | Post Trading |
|---|
| Shares in Issue | 1.34 bn | Prev Close | 1.44p |
|---|
| PE Ratio | | Market Cap | £20.80 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.463004 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 4.378498 | Quick Ratio | 4.378498 |
|---|
Hemogenyx Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 30/01/20 | PLAC | Peter Redmond | NED | 555,556 @ £0.02 | £10,000.00 |
| 03/07/19 | TIN | Vladislav Sandler | CEO | 1,066,667 @ £0.00 | £0.00 |
| 12/02/18 | BUY | Adrian Thorpe Beeston | RES | 200,000 @ £0.02 | £4,200.00 |
| 07/02/18 | BUY | Vladislav Sandler | CEO | 26,800 @ £0.02 | £635.00 |
| 11/10/17 | BUY | Adrian Thorpe Beeston | RES | 400,000 @ £0.03 | £11,840.00 |
| 10/10/17 | BUY | Peter Redmond | NED | 155,000 @ £0.03 | £4,859.00 |
| 10/10/17 | BUY | Adrian Thorpe Beeston | RES | 317,683 @ £0.03 | £9,848.00 |
Hemogenyx Pharmaceuticals PLC News
